Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06941298 · ClinicalTrials.gov registry record · NA

Neural and Psychiatric Consequences of Cannabis Use in Adolescents

A NA study of Depression and Cannabis Use, sponsored by University of Miami.

Recruiting
Registry status
NA
Development phase
280
Enrollment target
2
Study locations

NCT06941298: Recruiting NA study of Depression and Cannabis Use, sponsored by University of Miami.

NCT06941298 is a NA study of Depression and Cannabis Use that is actively recruiting participants, run by University of Miami. The registered enrollment target is 280 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (64% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06941298, a NA study of Depression and Cannabis Use, is actively recruiting participants, sponsored by University of Miami.

RECRUITING
Registry status
NA
Development phase
280 participants
Enrollment target
2
Study locations

Study Summary

The goal of this study is to investigate the effects of cannabis on brain function among adolescents with depression.

Primary Outcome

Scores range from 0-63 with a higher score indicating higher depression severity

Conditions Studied

Interventions

  • BEHAVIORAL Neuroimaging Investigation

Study Locations (2)

Florida

  • University of Miami Clinical Research Building - Miami

New York

  • Nathan Kline Institute - Orangeburg

Trial Details

FieldValue
Enrollment Target 280 participants
Start Date 2025-03-04
Est. Completion 2029-06-01
Phase NA
University of Miami

721 total trials

What NCT06941298 shows while recruiting

NCT06941298 is an interventional study that assigns participants to a tested intervention. The registered 280 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (64% lower).

The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Neuroimaging Investigation is the first listed.

NCT06941298 reports a single indexed study location in Florida, New York.

Frequently Asked Questions

What is clinical trial NCT06941298 about?

NCT06941298 is a clinical study titled "Neural and Psychiatric Consequences of Cannabis Use in Adolescents". The goal of this study is to investigate the effects of cannabis on brain function among adolescents with depression.

What is the current status of trial NCT06941298?

This trial is currently recruiting. It is a NA study. The enrollment target is 280 participants. The study started on 2025-03-04. Estimated completion is 2029-06-01.

What conditions does trial NCT06941298 study?

This clinical trial studies the following conditions: Depression, Cannabis Use.

What interventions are being tested in trial NCT06941298?

The interventions under investigation include: Neuroimaging Investigation (BEHAVIORAL).

Who is sponsoring clinical trial NCT06941298?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06941298 being conducted?

This trial has 2 study locations across Florida, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06941298's enrollment target sits among peer trials

280 158th of 679 higher than 521 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04084730 · 280 participants · Phase 2

    Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer

  • NCT04518657 · 280 participants · NA

    Internet-Delivered Lifestyle Physical Activity Intervention for Cognitive Processing Speed in Multiple Sclerosis

  • NCT04634916 · 280 participants · NA

    Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System

  • NCT04829617 · 280 participants · NA

    Promoting Well-being and Health in Heart Failure

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT06941298, the US trial registry maintained by the National Library of Medicine. NCT06941298 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.